Hypocretin/Orexin Neuropeptides: Participation in the Control of Sleep- Wakefulness Cycle and Energy Homeostasis
Author(s): A. Nunez, M. L. Rodrigo-Angulo, I. De Andres, M. Garzon. Dept. Anatomia, Histologia y Neurociencia. Fac. Medicina, Universidad Autonoma de Madrid, c/ Arzobispo Morcillo 4, 28029 Madrid, Spain., Spain
Journal Name: Current Neuropharmacology
Hypocretins or orexins (Hcrt/Orx) are hypothalamic neuropeptides that are synthesized by neurons located mainly in the perifornical area of the posterolateral hypothalamus. These hypothalamic neurons are the origin of an extensive and divergent projection system innervating numerous structures of the central nervous system. In recent years it has become clear that these neuropeptides are involved in the regulation of many organic functions, such as feeding, thermoregulation and neuroendocrine and cardiovascular control, as well as in the control of the sleep-wakefulness cycle. In this respect, Hcrt/Orx activate two subtypes of G protein-coupled receptors (Hcrt/Orx1R and Hcrt/Orx2R) that show a partly segregated and prominent distribution in neural structures involved in sleep-wakefulness regulation. Wakefulnessenhancing and/or sleep-suppressing actions of Hcrt/Orx have been reported in specific areas of the brainstem. Moreover, presently there are animal models of human narcolepsy consisting in modifications of Hcrt/Orx receptors or absence of these peptides. This strongly suggests that narcolepsy is the direct consequence of a hypofunction of the Hcrt/Orx system, which is most likely due to Hcrt/Orx neurons degeneration. The main focus of this review is to update and illustrate the available data on the actions of Hcrt/Orx neuropeptides with special interest in their participation in the control of the sleep-wakefulness cycle and the regulation of energy homeostasis. Current pharmacological treatment of narcolepsy is also discussed.
Keywords: Posterior lateral hypothalamic area, hypocretin neurons, orexin neurons, perifornical area, sleep-wakefulness, food intake
Current Neuropharmacology
Title: Hypocretin/Orexin Neuropeptides: Participation in the Control of Sleep- Wakefulness Cycle and Energy Homeostasis
Author(s):A. Nunez, M. L. Rodrigo-Angulo, I. De Andres and M. Garzon
Affiliation:Dept. Anatomia, Histologia y Neurociencia. Fac. Medicina, Universidad Autonoma de Madrid, c/ Arzobispo Morcillo 4, 28029 Madrid, Spain.
Keywords:Posterior lateral hypothalamic area, hypocretin neurons, orexin neurons, perifornical area, sleep-wakefulness, food intake
Abstract: Hypocretins or orexins (Hcrt/Orx) are hypothalamic neuropeptides that are synthesized by neurons located mainly in the perifornical area of the posterolateral hypothalamus. These hypothalamic neurons are the origin of an extensive and divergent projection system innervating numerous structures of the central nervous system. In recent years it has become clear that these neuropeptides are involved in the regulation of many organic functions, such as feeding, thermoregulation and neuroendocrine and cardiovascular control, as well as in the control of the sleep-wakefulness cycle. In this respect, Hcrt/Orx activate two subtypes of G protein-coupled receptors (Hcrt/Orx1R and Hcrt/Orx2R) that show a partly segregated and prominent distribution in neural structures involved in sleep-wakefulness regulation. Wakefulnessenhancing and/or sleep-suppressing actions of Hcrt/Orx have been reported in specific areas of the brainstem. Moreover, presently there are animal models of human narcolepsy consisting in modifications of Hcrt/Orx receptors or absence of these peptides. This strongly suggests that narcolepsy is the direct consequence of a hypofunction of the Hcrt/Orx system, which is most likely due to Hcrt/Orx neurons degeneration. The main focus of this review is to update and illustrate the available data on the actions of Hcrt/Orx neuropeptides with special interest in their participation in the control of the sleep-wakefulness cycle and the regulation of energy homeostasis. Current pharmacological treatment of narcolepsy is also discussed.
A. Nunez, M. L. Rodrigo-Angulo, I. De Andres and M. Garzon, " Hypocretin/Orexin Neuropeptides: Participation in the Control of Sleep- Wakefulness Cycle and Energy Homeostasis", Current Neuropharmacology (2009) 7: 50. https://doi.org/10.2174/157015909787602797
Commentary (Research Highlights: Targeted Inhibition of miR-155 Promotes Post-Stroke Neovascularization and Functional Recovery)
CNS & Neurological Disorders - Drug Targets
Smart Phones As a Viable Data Collection Tool in Low-resource Settings: Case Study of Rwandan Community Health Workers
Neuroscience and Biomedical Engineering (Discontinued)
Structure and Function Relationship in Prolyl Oligopeptidase
Central Nervous System Agents in Medicinal Chemistry
Schwann Cell Transplantation for CNS Repair
The Test Your Memory (TYM) Test Outperforms the MMSE in the Detection of MCI and Dementia
Current Alzheimer Research
Cytochrome P450 in Neurological Disease
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
Acknowledgement To Reviewers
Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease
Reacting to Stress: Radical Cellular Pathways for Novel Drug Development
Current Neurovascular Research
Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
Current Drug Safety
Phytoconstituents and their Possible Mechanistic Profile for Alzheimer's Disease – A Literature Review
White Matter Damage Along the Uncinate Fasciculus Contributes to Cognitive Decline in AD and DLB
Metal Protein Attenuating Compounds (MPACs): An Emerging Approach for the Treatment of Neurodegenerative Disorders
Current Bioactive Compounds
Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review
Combinatorial Chemistry & High Throughput Screening
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Recent Patents on CNS Drug Discovery (Discontinued)
A Pathological Brain Detection System based on Extreme Learning Machine Optimized by Bat Algorithm
Between Bench and Bed Side: PI3K Inhibitors
Current Molecular Pharmacology